Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers, Journal of Theoretical Biology, vol.335, p.235, 2013. ,
DOI : 10.1016/j.jtbi.2013.06.036
URL : https://hal.archives-ouvertes.fr/hal-00836032
Designing proliferating cell population models with functional targets for control by anti-cancer drugs, Discrete and Continuous Dynamical Systems - Series B, vol.18, issue.4, p.865, 2013. ,
DOI : 10.3934/dcdsb.2013.18.865
URL : https://hal.archives-ouvertes.fr/hal-00726195
Individual-based and continuum models of growing cell populations: a comparison, Journal of Mathematical Biology, vol.14, issue.1, p.657, 2009. ,
DOI : 10.1103/PhysRevE.71.051910
Optimization of an in vitro chemotherapy to avoid resistant tumours, Journal of Theoretical Biology, vol.413, p.24, 2017. ,
DOI : 10.1016/j.jtbi.2016.11.009
Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1860, issue.11, p.2627, 2016. ,
DOI : 10.1016/j.bbagen.2016.06.009
URL : https://hal.archives-ouvertes.fr/hal-01321535
Effects of an advection term in nonlocal Lotka???Volterra equations, Communications in Mathematical Sciences, vol.14, issue.4, p.1181, 2016. ,
DOI : 10.4310/CMS.2016.v14.n4.a16
URL : https://hal.archives-ouvertes.fr/hal-01237529
Evolutionary dynamics of phenotype-structured populations: from individual-level mechanisms to population-level consequences, Zeitschrift f??r angewandte Mathematik und Physik, vol.396, issue.4, p.100, 2016. ,
DOI : 10.1016/j.jtbi.2015.11.028
Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation, Cancer Research, vol.75, issue.6, p.930, 2015. ,
DOI : 10.1158/0008-5472.CAN-14-2103
URL : https://hal.archives-ouvertes.fr/hal-01237893
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work, Nature Reviews Cancer, vol.196, issue.7, p.487, 2012. ,
DOI : 10.1126/science.860134
Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer. Part 1: Biological Facts and Studies in Drug Resistance, Current Stem Cell Reports, vol.6, issue.9, p.253, 2017. ,
DOI : 10.1038/ncomms7169
URL : https://hal.archives-ouvertes.fr/hal-01574685
Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer, Part 2: from Theoretical Biology to Mathematical Models, Current Stem Cell Reports, vol.252, issue.1, p.260, 2017. ,
DOI : 10.1016/j.jde.2012.02.006
URL : https://hal.archives-ouvertes.fr/hal-01558479
MULTIDRUG RESISTANCE IN CANCER: ROLE OF ATP-DEPENDENT TRANSPORTERS, Nature Reviews Cancer, vol.2, issue.1, p.48, 2002. ,
DOI : 10.1038/nrc706
On the intrinsic inevitability of cancer: From foetal to fatal attraction, Seminars in Cancer Biology, vol.21, issue.3, p.183, 2011. ,
DOI : 10.1016/j.semcancer.2011.05.003
Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells, Cancer and Metastasis Reviews, vol.32, issue.6119, p.423, 2013. ,
DOI : 10.1002/med.20239
Bifurcation dynamics in lineage-commitment in bipotent progenitor cells, Developmental Biology, vol.305, issue.2, p.695, 2007. ,
DOI : 10.1016/j.ydbio.2007.02.036
Evolution and tinkering, Science, vol.196, issue.4295, p.1161, 1977. ,
DOI : 10.1126/science.860134
Cancer Stem Cells: Distinct Entities or Dynamically Regulated Phenotypes?, Cancer Research, vol.72, issue.3, p.576, 2012. ,
DOI : 10.1158/0008-5472.CAN-11-3070
URL : http://cancerres.aacrjournals.org/content/canres/72/3/576.full.pdf
Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations, Biology Direct, vol.28, issue.3, p.43, 2016. ,
DOI : 10.1038/leu.2013.337
URL : https://hal.archives-ouvertes.fr/hal-01355314
Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies, ESAIM: Mathematical Modelling and Numerical Analysis, vol.47, issue.2, p.377, 2013. ,
DOI : 10.1051/m2an/2012031
URL : https://hal.archives-ouvertes.fr/hal-00714274
Modeling the Effects of Space Structure and Combination Therapies on Phenotypic Heterogeneity and Drug Resistance in Solid Tumors, Bulletin of Mathematical Biology, vol.65, issue.1, p.1, 2015. ,
DOI : 10.1002/(SICI)1097-0215(19960126)65:3<365::AID-IJC15>3.0.CO;2-9
URL : https://hal.archives-ouvertes.fr/hal-00921266
Metronomic chemotherapy: new rationale for new directions, Nature Reviews Clinical Oncology, vol.1805, issue.8, p.455, 2010. ,
DOI : 10.1016/0002-9394(77)90132-5
Transport equations in biology, 2007. ,
Hedging one's evolutionary bets, revisited, Trends in Ecology & Evolution, vol.4, issue.2, p.41, 1989. ,
DOI : 10.1016/0169-5347(89)90138-9
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance, Nature, vol.163, issue.7658, p.431, 2017. ,
DOI : 10.1016/j.cell.2015.11.018
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations, Cell, vol.141, issue.1, p.69, 2010. ,
DOI : 10.1016/j.cell.2010.02.027
Contrôle optimal, Mathscinet MR2224013, p.49001, 2005. ,
The strategy of genes, 1957. ,
Immunological aspects of cancer chemotherapy, Nature Reviews Immunology, vol.313, issue.1, p.59, 2008. ,
DOI : 10.4049/jimmunol.172.4.2039
Immune parameters affecting the efficacy of chemotherapeutic regimens, Nature Reviews Clinical Oncology, vol.23, issue.3, p.151, 2011. ,
DOI : 10.1200/JCO.2005.02.0818